Literature DB >> 21814154

Cryptococcus gattii genotype VGI infection in New England.

Russell J McCulloh1, Raina Phillips, John R Perfect, Edmond J Byrnes, Joseph Heitman, Elizabeth Dufort.   

Abstract

Cryptococcus gattii is a known, emerging infectious disease pathogen predominantly in the Pacific Northwest, the United States, and British Columbia, Canada. We report a case of an immunocompetent adolescent from New England who had severe pulmonary and central nervous system infection caused by the VGI genotype of C. gattii.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21814154      PMCID： PMC3222723          DOI： 10.1097/INF.0b013e31822d14fd

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  15 in total

1.  The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy.

Authors:  Ismail Zafer Ecevit; Cornelius J Clancy; Ilona M Schmalfuss; M Hong Nguyen
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

2.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

3.  Emergence of Cryptococcus gattii-- Pacific Northwest, 2004-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-07-23       Impact factor: 17.586

4.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).

Authors:  S E Kidd; F Hagen; R L Tscharke; M Huynh; K H Bartlett; M Fyfe; L Macdougall; T Boekhout; K J Kwon-Chung; W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

5.  Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Authors:  K J Kwon-Chung; I Polacheck; J E Bennett
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

Review 6.  Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Authors:  D H Mitchell; T C Sorrell; A M Allworth; C H Heath; A R McGregor; K Papanaoum; M J Richards; T Gottlieb
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

7.  Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.

Authors:  Edmond J Byrnes; Wenjun Li; Yonathan Lewit; Hansong Ma; Kerstin Voelz; Ping Ren; Dee A Carter; Vishnu Chaturvedi; Robert J Bildfell; Robin C May; Joseph Heitman
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

8.  Isolation of Cryptococcus neoformans var. gattii from an Asian patient in France: evidence for dormant infection in healthy subjects.

Authors:  F Dromer; O Ronin; B Dupont
Journal:  J Med Vet Mycol       Date:  1992

9.  Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.

Authors:  S M Levitz; M P Dupont; E H Smail
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079
View more
  12 in total

1.  Cryptococcus gattii as an important fungal pathogen of western North America.

Authors:  Kieren A Marr
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

2.  Case Series: Report of the First Two Human Indigenous Cases of Cryptococcus gattii Infection in Eastern Canada.

Authors:  Jessica St-Pierre; Philippe J Dufresne; Alex Carignan; Émilie Lévesque; Francis Bernard; Jean Longtin; Louiselle LeBlanc
Journal:  Mycopathologia       Date:  2017-10-30       Impact factor: 2.574

Review 3.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

Review 5.  A Call to Arms: Quest for a Cryptococcal Vaccine.

Authors:  Marley C Caballero Van Dyke; Floyd L Wormley
Journal:  Trends Microbiol       Date:  2017-11-02       Impact factor: 17.079

Review 6.  Current trends in the prevalence of Cryptococcus gattii in the United States and Canada.

Authors:  Ana Espinel-Ingroff; Sarah E Kidd
Journal:  Infect Drug Resist       Date:  2015-05-11       Impact factor: 4.003

7.  Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolates.

Authors:  Shawn R Lockhart; Naureen Iqbal; Julie R Harris; Nina T Grossman; Emilio DeBess; Ron Wohrle; Nicola Marsden-Haug; Duc J Vugia
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

8.  Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice.

Authors:  Ashok K Chaturvedi; Rumanasma S Hameed; Karen L Wozniak; Camaron R Hole; Chrissy M Leopold Wager; Susan T Weintraub; Jose L Lopez-Ribot; Floyd L Wormley
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

9.  Development of an aerosol model of Cryptococcus reveals humidity as an important factor affecting the viability of Cryptococcus during aerosolization.

Authors:  Deborah J Springer; Divey Saini; Edmond J Byrnes; Joseph Heitman; Richard Frothingham
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.

Authors:  Rachel M Smith; Adamma Mba-Jonas; Mathieu Tourdjman; Trisha Schimek; Emilio DeBess; Nicola Marsden-Haug; Julie R Harris
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.